Skip to main content
. 2021 Jul 31;26:48. doi: 10.4103/jrms.JRMS_103_20

Table 5.

Unfavorable prognostic factors for complete response (n=43)

Characteristics Univariate analysis Multivariate analysis


OR 95% CI P OR 95% CI P
Age (year)
 <32 1 (references) -
 ≥32 0.970 0.228-4.151 0.970
Histologic grade
 I 1 (references) - 1 (references) -
 II 7.429 1.121-49.244 0.038 4.446 0.405-48.785 0.222
BMI (kg/m2)
 <27.5 1 (references) -
 ≥27.5 1.600 0.393-6.509 0.511
PCOS
 No 1 (references) -
 Yes 0.962 0.237-3.899 0.956
Metformin
 No 1 (references) -
 Yes 1.852 0.265-12.947 0.535
DM
 No 1 (references) -
 Yes 1.852 0.265-12.947 0.535
HTN
 No 1 (references) -
 Yes 2.700 0.154-47.392 0.497
EM thickness before treatment (mm)
 <15 1 (references) -
 ≥1 1.429 0.326-6.257 0.636
EM thickness after treatment (mm)
 <7 1 (references) -
 ≥7 8.000 1.650-38.790 0.010
EM ratio (after treatment/before treatment)
 <0.55 1 (references) - 1 (references) -
 ≥0.55 10.500 2.075-53.142 0.004 19.018 1.854-195.078 0.013
Treatment
 Oral progestin+LNG-IUD 1 (references) - 1 (references) −1.356-134.069 0.026
 Oral progestin 8.000 1.650-38.790 0.010 13.483

Bold numbers indicate P<0.05. OR=Odds ratio; CI=Confidence interval; BMI=Body mass index; PCOS=Polycystic ovary syndrome; DM=Diabetes mellitus; HTN=Hypertension; EM=Endometrium; LNG-IUD=Levonorgestrel-intrauterine device